Overview / Abstract: |
Nephrology specialists Carla Nester, MD, and Andrew Bomback, MD, delve into the rare and difficult-to-diagnose disease state of C3 glomerulopathy, a membranoproliferative form of glomerulonephritis. Recent guideline updates and recommended clinical management strategies for the treatment of glomerular disease are reviewed. In addition, the specific pathophysiology, clinical features and diagnosis of C3 glomerulopathy are discussed, as well as the global patient burden of disease and concomitant disease states caused by complement dysregulation. Insight into the historical management of C3 glomerulopathy and targeted therapies currently undergoing evaluation in late clinical trials are provided. Finally, patient resources, supportive measures and clinical perspective on the future of C3 glomerulopathy management are discussed by the faculty. |
Expiration |
Dec 15, 2023 |
Format |
Online, Podcast |
Credits / Hours |
1.00 |
Accreditation |
AMA, ANCC,CA-BRN, Pharmacology |
Presenters / Authors / Faculty |
Andrew S. Bomback, MD, MPH Carla M. Nester MD, MSA |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Novartis Pharmaceutical Corporation. |
Keywords / Search Terms |
Annenberg Center for Health Sciences at Eisenhower Glomerular Disease Overview, Pathogenesis, Patient Burden of Disease, Diagnosis, Standard of Care, Emerging Treatment, Patient Resources Free CE CME |